AMLs protect themselves against chemotherapy-related apoptosis by producing adhesion molecules such as VLA-4 which, together with VCAM-1, not only promote proliferation in AML and MSCs via the nuclear factor kappa B (NF-κB) pathway but additionally ensure integration into the vascular niche [63,64,65]. Here, VCAM1 is linked to acute myeloid leukemia.